FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024882100> ?p ?o ?g. }

• W2024882100 endingPage "20" @default.
• W2024882100 startingPage "14" @default.
• W2024882100 abstract "The aim of this study was to compare the effect of several commercially available topoisomerase II inhibitors on the proliferation of retinal pigment epithelium (RPE) cells in vitro and to test the toxicity and efficacy of the inhibitor against experimental proliferative vitreoretinopathy (PVR).Three different topoisomerase II inhibitors (etoposide, doxorubicin, and daunorubicin) were tested in vitro. Rabbit RPE cells were cultured with or without the drugs at various concentrations. An MTT assay was used to determine the cell viability at 48 h and 96 h. Etoposide, a drug which showed a broad therapeutic range in vitro, was injected to the rabbit eye for the evaluation of the toxicity in vivo. Therapeutic effects of an intravitreal injection of etoposide were evaluated in an experimental PVR model induced by the intravitreal implantation of RPE cells in rabbits.All tested topoisomerase II inhibitors showed a significant reduction of cell viability in vitro. The slope of the dose-response curve was slowly declined for etoposide, and declined sharply for doxorubicin and daunorubicin. Therefore, etoposide was selected for further toxicity and efficacy studies in vivo. There was no significant change in b-wave amplitudes in the etoposide-injected eyes (0.02 mg, 10 microg/mL) after 2 weeks, but a significant reduction occurred in the etoposide-injected eyes (0.2 mg, 100 microg/mL). In the study of the experimental model of PVR, the rabbit eyes injected with RPE cells and etoposide (0.02 mg, 10 microg/mL) showed a significantly lower grading of PVR than that of the control eyes (injected RPE cells and PBS).These results indicate that etoposide would be an adjunctive for the prevention of PVR. Further pharmacokinetic study of the intravitreal injection of etoposide is required." @default.
• W2024882100 created "2016-06-24" @default.
• W2024882100 creator A5037905679 @default.
• W2024882100 creator A5039616986 @default.
• W2024882100 creator A5048953421 @default.
• W2024882100 creator A5052214110 @default.
• W2024882100 creator A5080298777 @default.
• W2024882100 creator A5089671704 @default.
• W2024882100 date "2007-02-01" @default.
• W2024882100 modified "2023-10-17" @default.
• W2024882100 title "Effects of Topoisomerase II Inhibitors on Retinal Pigment Epithelium And Experimental Proliferative Vitreoretinopathy" @default.
• W2024882100 cites W1497840515 @default.
• W2024882100 cites W1968850051 @default.
• W2024882100 cites W1972227366 @default.
• W2024882100 cites W1975168418 @default.
• W2024882100 cites W1978122258 @default.
• W2024882100 cites W1991674284 @default.
• W2024882100 cites W1992619483 @default.
• W2024882100 cites W1996001880 @default.
• W2024882100 cites W1998878112 @default.
• W2024882100 cites W2002370145 @default.
• W2024882100 cites W2030077205 @default.
• W2024882100 cites W2037022487 @default.
• W2024882100 cites W2045421163 @default.
• W2024882100 cites W2051907464 @default.
• W2024882100 cites W2054486764 @default.
• W2024882100 cites W2087661157 @default.
• W2024882100 cites W2102964731 @default.
• W2024882100 cites W2103489107 @default.
• W2024882100 cites W2105253056 @default.
• W2024882100 cites W2114232337 @default.
• W2024882100 cites W2132747667 @default.
• W2024882100 cites W2141378426 @default.
• W2024882100 cites W2158269015 @default.
• W2024882100 doi "https://doi.org/10.1089/jop.2006.0059" @default.
• W2024882100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17341145" @default.
• W2024882100 hasPublicationYear "2007" @default.
• W2024882100 type Work @default.
• W2024882100 sameAs 2024882100 @default.
• W2024882100 citedByCount "10" @default.
• W2024882100 countsByYear W20248821002012 @default.
• W2024882100 countsByYear W20248821002015 @default.
• W2024882100 countsByYear W20248821002016 @default.
• W2024882100 countsByYear W20248821002017 @default.
• W2024882100 countsByYear W20248821002018 @default.
• W2024882100 countsByYear W20248821002020 @default.
• W2024882100 countsByYear W20248821002022 @default.
• W2024882100 crossrefType "journal-article" @default.
• W2024882100 hasAuthorship W2024882100A5037905679 @default.
• W2024882100 hasAuthorship W2024882100A5039616986 @default.
• W2024882100 hasAuthorship W2024882100A5048953421 @default.
• W2024882100 hasAuthorship W2024882100A5052214110 @default.
• W2024882100 hasAuthorship W2024882100A5080298777 @default.
• W2024882100 hasAuthorship W2024882100A5089671704 @default.
• W2024882100 hasConcept C118487528 @default.
• W2024882100 hasConcept C126322002 @default.
• W2024882100 hasConcept C147897179 @default.
• W2024882100 hasConcept C150903083 @default.
• W2024882100 hasConcept C185592680 @default.
• W2024882100 hasConcept C202751555 @default.
• W2024882100 hasConcept C207001950 @default.
• W2024882100 hasConcept C2776694085 @default.
• W2024882100 hasConcept C2778119113 @default.
• W2024882100 hasConcept C2779059073 @default.
• W2024882100 hasConcept C2780428090 @default.
• W2024882100 hasConcept C2780827179 @default.
• W2024882100 hasConcept C2781021840 @default.
• W2024882100 hasConcept C2781303535 @default.
• W2024882100 hasConcept C29730261 @default.
• W2024882100 hasConcept C55493867 @default.
• W2024882100 hasConcept C71924100 @default.
• W2024882100 hasConcept C86803240 @default.
• W2024882100 hasConcept C98274493 @default.
• W2024882100 hasConceptScore W2024882100C118487528 @default.
• W2024882100 hasConceptScore W2024882100C126322002 @default.
• W2024882100 hasConceptScore W2024882100C147897179 @default.
• W2024882100 hasConceptScore W2024882100C150903083 @default.
• W2024882100 hasConceptScore W2024882100C185592680 @default.
• W2024882100 hasConceptScore W2024882100C202751555 @default.
• W2024882100 hasConceptScore W2024882100C207001950 @default.
• W2024882100 hasConceptScore W2024882100C2776694085 @default.
• W2024882100 hasConceptScore W2024882100C2778119113 @default.
• W2024882100 hasConceptScore W2024882100C2779059073 @default.
• W2024882100 hasConceptScore W2024882100C2780428090 @default.
• W2024882100 hasConceptScore W2024882100C2780827179 @default.
• W2024882100 hasConceptScore W2024882100C2781021840 @default.
• W2024882100 hasConceptScore W2024882100C2781303535 @default.
• W2024882100 hasConceptScore W2024882100C29730261 @default.
• W2024882100 hasConceptScore W2024882100C55493867 @default.
• W2024882100 hasConceptScore W2024882100C71924100 @default.
• W2024882100 hasConceptScore W2024882100C86803240 @default.
• W2024882100 hasConceptScore W2024882100C98274493 @default.
• W2024882100 hasIssue "1" @default.
• W2024882100 hasLocation W20248821001 @default.
• W2024882100 hasLocation W20248821002 @default.
• W2024882100 hasOpenAccess W2024882100 @default.
• W2024882100 hasPrimaryLocation W20248821001 @default.
• W2024882100 hasRelatedWork W1991042431 @default.

• next